EFFECT OF STENT BOOST IMAGING GUIDED PERCUTANEOUS CORONARY INTERVENTION ON MID-TERM ANGIOGRAPHIC AND CLINICAL OUTCOMES  by Choi, Cheol Ung et al.
    
  i2 SUMMIT   
E1879
JACC April 5, 2011
Volume 57, Issue 14
EFFECT OF STENT BOOST IMAGING GUIDED PERCUTANEOUS CORONARY INTERVENTION ON MID-TERM 
ANGIOGRAPHIC AND CLINICAL OUTCOMES
i2 Poster Contributions
Ernest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 9:30 a.m.-10:45 a.m.
Session Title: CTA/MRI, Imaging in the Cath Lab, Angiography
Abstract Category: 2. Imaging in the Cath Lab; Angiography & QCA
Session-Poster Board Number: 2510-544
Authors: Cheol Ung Choi, Dong Joo Oh, Sureshkumar Ramasamy, Kanhaiya L. Poddar, Yun Kyung Kim, Jin Oh Na, Hong Euy Lim, Jin Won Kim, Eung 
Ju Kim, Seung-Woon Rha, Chang Gyu Park, Hong Seog Seo, Cardiovascular Center, Korea University, Guro Hospital, Seoul, South Korea
Background: The gold standard evaluation method of adequate stent expansion after percutaneous coronary intervention (PCI) is intravascular 
ultrasound (IVUS), but routine use is costly and time-consuming. Stent boost is a new technique improving fluoroscopy-based assessment of stent 
expansion. The purpose of this study was to assess the impact of stent boost enhancement guided PCI on mid-term angiographic and clinical 
outcomes.
Methods: A total 870 consecutive patients (pts, Age; 64.34 ± 11.61, Men; 64.5 %) undergoing PCI with drug-eluting stents (DESs). The pts were 
divided into no-stent boost group (n=569 pts) and stent boost group (n=301 pts). The 6-month angiographic and clinical outcomes were compared 
between the two groups.
Results: Baseline clinical characteristics were similar between the two groups except stable angina was more in no-boost group, whereas acute 
coronary syndrome and right coronary artery as the target vessel was more in boost group. At 1-month, clinical outcomes were similar between the 
two groups. At 6-month, late loss, binary restenosis, target lesion revascularization (TLR), TLR- and target vessel revascularization (TVR)-major adverse 
cardiac events (MACEs) were lower in stent boost group compared with those of no-stent boost group (Table). 
Conclusions: We suggest that routine clinical use of stent boost during PCI is useful and associated with better mid-term clinical outcomes. 
